Multimodular Treatment in Head & Neck Squamous Cell Carcinoma (HNSCC)

 

The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning evaluate the role of induction, definitive concurrent chemotherapy and sequential therapy in locally advanced head and neck squamous cell carcinoma (HNSCC)? (1-no, not at all; 5-yes absolutely)

2. Did this E-Learning describe organ preservation strategies? (1-no, not at all; 5-yes absolutely)

3. Did this E-Learning discuss the common indications for postoperative chemoradiation? (1-no, not at all; 5-yes absolutely)

4. Did this E-Learning define the role of bioradiotherapy with cetuximab? (1-not at all; 5-absolutely)

5. Did this E-Learning allow you to understand HPV-associated oropharyngeal cancers? (1-not at all; 5-absolutely)

6. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

7. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

8. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

9. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

10. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: